Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Withdrawn 4Unknown 4Recruiting 3Completed 3Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1Breast 1

Conditions

Small Cell Lung Carcinoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × Thymalfasin × Clear all
NCT02535988 2023-09-21

Abscopal Effect for Metastatic Colorectal Cancer

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT02542930 2019-03-26

Abscopal Effect for Metastatic Non-small Cell Lung Cancer.

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02542137 2019-03-21

Abscopal Effect for Metastatic Small Cell Lung Cancer

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Thoracic

Small Cell Lung Carcinoma

NCT00935558 2012-05-31

Dendritic Cell Based Therapy for Breast Cancer Patients

Herlev Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡